ACR 2016

Prognostic Value of Autoantibodies in Predicting Arthritis Progression

Patients with clinically suspect arthralgia who have circulating anti-citrullinated protein antibodies (ACPAs) and rheumatoid factor (RF) are at an increased risk of clinical arthritis progression, according to research presented at the American College of Rheumatology 2016 annual meeting. Robin M ten Brinck, PhD candidate from the Department of Rheumatology at Leiden University Medical Center, the…

Sustained Improvements in PsA Domains With Secukinumab

WASHINGTON, DC — Researchers evaluating the 3-year efficacy of secukinumab found that it safe and efficacious in the treatment of psoriatic arthritis (PsA) across multiple dosages, according to recent research recently presented at the American College of Rheumatology 2016 annual meeting. Philip J Mease, MD, from the Swedish Medical Center and University of Washington, Seattle,…

Next post in ACR 2016 Coverage